Find out more about how The Lecture List works.
Coronavirus situation updateOur lecture organisers may or may not have had time to update their events with cancellation notices. Clearly social gatherings are to be avoided and that includes lectures. STAY AT HOME FOLKS, PLEASE. |
Find out what you can do to keep The Lecture List online
 |
|
A symposium organised by the Academy of Medical Sciences Forum and sponsored by GlaxoSmithKline
There is a widespread concern about the limited evidence available for both
efficacy and safety of many medicines used in children. The reasons are
complex. Children only rarely develop serious illnesses. This makes
recruitment for clinical trials difficult and provides little incentive for
manufacturers to develop special formulations of their products. When
children do fall ill doctors often have to prescribe adult formulations that
may be unsuitable and doses that have not been validated in that age group.
This symposium brings together leading experts from academia, the health
service, industry and regulatory bodies to review the current situation and
to discuss ways and means of bringing about improvements.
Speaker(s): |
Sir Alasdair Breckenridge (chair) | talks |
|
|
Date and Time: |
14 June 2004 at 9:00 am |
Duration: | Full Day |
|
|
Venue: |
Royal Institute of British Architects (RIBA) |
Organised by: |
Academy of Medical Sciences |
|
|
Tickets: |
£150; £60 Academy Fellows; £25 students; free to some forum members |
Available from: |
View the programme and register online at Contact: Ms Laurence Ehlers 020 7969 5287 or laurence.ehlers@acmedsci.ac.uk |
Register to tell a friend about this lecture.
If you would like to comment about this lecture, please register here.
©2003-2006 Niminim Limited. Created by 
Any ad revenue is entirely reinvested into the Lecture List's operating fund
